Skip to content

HORIZONH2020FP7

Instituto Portugues de Oncologia do Porto Francisco Gentil, Epe

Country
PTPortugal
Defence projects
0
Projects, all programmes
14
As coordinator
0
EU contribution (CORDIS)
EUR 3,518,663
Active
2009 to 2025

Projects

14 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EURECAEURopean Epitranscriptomics of Cancer AcademyHORIZON2025ParticipantNot stated
PROSTAMETA Comprehensive Translational Research and Training Pipeline Harnessing Lipid Metabolism to Improve Prostate Cancer Management and Educate Young Researchers in Tackling Complex DiseaseHORIZON2024ParticipantEUR 243,403
ONCOSCREENA European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathwaysHORIZON2023ParticipantEUR 382,500
CCI4EUCOMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPEHORIZON2023Third partyNot stated
AIDAAn Artificially Intelligent Diagnostic Assistant for gastric inflammationHORIZON2023ParticipantEUR 791,875
PRIME-ROSEPRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical TrialsHORIZON2023ParticipantEUR 142,375
PAINLESSPain relief in palliative care of cancer using home-based neuromodulation and predictive biomarkersHORIZON2022ParticipantEUR 341,750
ONCOVALUEImplementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-timeHORIZON2022ParticipantEUR 424,435
4.UNCAN.euA Coordination and Support Action to prepare UNCAN.eu platformHORIZON2022ParticipantEUR 10,000
Instand-NGS4PIntegrated and standardized NGS workflows for Personalised therapyH20202020Third partyNot stated
MindGAPBridging the gap between Mind, Brain and Body: exosome role and monitoringH20202019ParticipantEUR 793,525
GlyCoCanExploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeuticsH20202015PartnerEUR 0
EPIDIACANDevelopment of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancerFP72010ParticipantEUR 330,000
CHIBCHAGenetic study of Common Hereditary Bowel Cancers in Hispania and the AmericasFP72009ParticipantEUR 58,800

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.